Jump to content

Mahidol-GPO’s human trials of its COVID-19 vaccine show promising results


Recommended Posts

Posted

TSNBg3wSBdng7ijMh1NgDnGiyAjIzDyuMuLXVAwr89Q-768x432.jpg

 

The first phase of human trials of Thailand’s vaccine candidate, jointly developed domestically by the Government Pharmaceutical Organization (GPO) and the Tropical Medicine Faculty of Mahidol University, has produced a promising human response in the volunteers, according to Prof. Dr. Pannee Pitisutthitham, acting head of the vaccine centre of the faculty.

 

Speaking via the Mahidol Channel, Professor Pannee said the vaccine candidate, called HXP-GPOVac, which is an inactivated virus type vaccine, was developed from a viral precursor, obtained from PATH, a global health organisation based in the United States, and was used in first phase of human trials among volunteers in March.

 

All 210 volunteers in the trials are in good health, free from Hepatitis B and C and are not suffering from an immune deficiency. The volunteers were separated into six groups, each was injected with differing dosages of vaccine, in order to assess the appropriate dosage to be used once approved. Some of the volunteers were given placebo instead, as a control measure.

 

Full Story: https://www.thaipbsworld.com/mahidol-gpos-human-trials-of-its-covid-19-vaccine-show-promising-results/

 

Logo-top-.png

-- © Copyright Thai PBS 2021-07-01
 
Posted

Thai COVID Vaccine Stimulates Strong Immunity in Phase1 Trial

 

123-e1625106139121.jpg

 

BANGKOK, July 1 (TNA) – A research has found that a COVID-19 vaccine jointly developed by Mahidol University and the Government Pharmaceutical Organization (GPO) stimulated strong immunity.

 

The university through its Mahidol Channel reported that the HXP-GPOVac vaccine proved to stimulate strong immunity among volunteers during its first stage of human trials.

 

HXP-GPOVac is an inactivated vaccine.

 

Full Story: https://tna.mcot.net/english-news-729596

 

tnalogo.jpg

-- © Copyright TNA 2021-07-01
 
Posted (edited)
41 minutes ago, snoop1130 said:

stimulated strong immunity.

stimulated strong immunity scepticism!

 

 

Edited by fangless
PS removed
  • Like 1
Posted

If Siam Bioscience cannot produce enough of well known and approved AZ, what they plan to do with home grown drug? gave it to CP to manufacture?

  • Like 1
Posted

Promising results means no volunteers died, yet. And if they do it would be a coincidence.

 

Awaiting some sort of publication of these 'promising' results.

 

 

 

Posted
18 minutes ago, MasterBaker said:

If Siam Bioscience cannot produce enough of well known and approved AZ, what they plan to do with home grown drug? gave it to CP to manufacture?

 

This Mahidol vaccine is manufactured using convetional means, grown in eggs, which, we're told is done here reliably and in high volumes.

Posted

Researchers Are Hatching a Low-Cost Coronavirus Vaccine

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

 

A new vaccine for Covid-19 that is entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. The vaccine, called NDV-HXP-S, is the first in clinical trials to use a new molecular design that is widely expected to create more potent antibodies than the current generation of vaccines. And the new vaccine could be far easier to make.

 

https://www.nytimes.com/2021/04/05/health/hexapro-mclellan-vaccine.html

  • Like 2
Posted
15 hours ago, snoop1130 said:

The university through its Mahidol Channel reported that the HXP-GPOVac vaccine proved to stimulate strong immunity among volunteers during its first stage of human trials.

A strong immunity against what exactly?

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.



×
×
  • Create New...